(Q51522370)

English

Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study.

scientific article published on 9 October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

0 references

Rebecca Lodwick

object named as

Rebecca Lodwick

4

0 references

object named as

Andrea de Luca

12

0 references

Geneviève Chêne

29

object named as

Genevieve Chene

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

9

object named as

Amanda Mocroft

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

Gerd Fätkenheuer

16

object named as

Gerd Fätkenheuer

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

15

object named as

Niels Obel

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

7

object named as

Ard van Sighem

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

Robert Zangerle

22

object named as

Robert Zangerle

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

Dominique Costagliola

3

object named as

Dominique Costagliola

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

Bruno Ledergerber

5

object named as

Bruno Ledergerber

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

Dimitrios Paraskevis

1 reference

ORCID Public Data File 2021

Andrew N Phillips

31

object named as

Andrew Phillips

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

Stéphane De Wit

14

object named as

Stephane De Wit

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

25

object named as

Laurence Meyer

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

Céline Fabre-Colin

27

object named as

Céline Fabre-Colin

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

Jesper Nørgaard Kjær

28

object named as

Jesper Kjaer

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

Cristina Mussini

18

object named as

Cristina Mussini

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

30

object named as

Jesper Grarup

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

10

object named as

Maria Dorrucci

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

Bernard Masquelier

11

object named as

Bernard Masquelier

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

13

object named as

Klaus Jansen

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

Cristoph Stephan

20

object named as

Cristoph Stephan

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

26

object named as

Jade Ghosn

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

author name string

Pursuing Later Treatment Option II (PLATO II) project team

1

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

Observational HIV Epidemiological Research Europe (COHERE) Group

2

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

Carlo Torti

6

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

Daniel Podzamczer

8

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

Giota Touoloumi

17

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

Antonella Castagna

19

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

Federico García

21

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

Xavier Duval

23

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

Santiago Pérez-Hoyos

24

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

publication date

9 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

Lancet Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

12

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

2

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

119-127

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970248-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970248-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintaining Antiretroviral Therapy Reduces the Risk of AIDS-Defining Events in Patients with Uncontrolled Viral Replication and Profound Immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970248-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970248-1

7 January 2021

based on heuristic

inferred from DOI database lookup

An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970248-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970248-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: an observational cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970248-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to combination antiretroviral therapy: variation by age.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970248-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Expanded European AIDS case definition

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970248-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970248-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed people

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970248-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970248-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970248-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in causes of death among adults infected by HIV between 2000 and 2005: The "Mortalité 2000 and 2005" surveys (ANRS EN19 and Mortavic).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970248-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of HIV in serious diseases other than AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970248-1

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970248-1

7 January 2021

based on heuristic

inferred from DOI database lookup

High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results of the ANRS 139 TRIO trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970248-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term probability of detecting drug-resistant HIV in treatment-naive patients initiating combination antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970248-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1473-3099(11)70248-1

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/21988895

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51522370&oldid=1855801846"